← Back to Analyst Consensus 
CLLS Buy
Cellectis S.A.
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 16, 2026 | Barclays | downgrade | Overweight → Underweight | — | 53% |
| Sep 15, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Sep 15, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Sep 15, 2026 | Citizens | downgrade | Market Outperform → Market Perform | — | 47% |
| May 28, 2026 | Barclays | initiate | — → Overweight | — | 53% |
| Apr 14, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| Dec 23, 2025 | Clear Street | initiate | — → Buy | $9 | 48% |
| Oct 17, 2025 | Barclays | maintain | Overweight → Overweight | $8 | 53% |
| May 13, 2025 | Barclays | maintain | Overweight → Overweight | $4 | 53% |
| Nov 5, 2024 | Barclays | maintain | Overweight → Overweight | $5 | 53% |
| Jun 12, 2024 | Oppenheimer | maintain | Outperform → Outperform | $10 | 52% |
| May 31, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $6 | 53% |
| Nov 1, 2023 | JMP Securities | reiterate | Market Outperform → Market Outperform | $6 | 53% |
| Aug 8, 2023 | Oppenheimer | reiterate | Outperform → Outperform | $11 | 52% |
| Aug 7, 2023 | JMP Securities | reiterate | Market Outperform → Market Outperform | $6 | 53% |
| Apr 5, 2023 | Citigroup | maintain | — → Buy | $16 | 54% |
| Mar 13, 2023 | Oppenheimer | maintain | — → Outperform | $13 | 52% |
| Mar 13, 2023 | JMP Securities | reiterate | — → Market Outperform | $6 | 53% |
| Jan 19, 2023 | JMP Securities | maintain | — → Market Outperform | $6 | 53% |
| May 24, 2022 | Goldman Sachs | maintain | — → Sell | $2 | 54% |
| May 18, 2022 | Baird | upgrade | Neutral → Outperform | $0 | 55% |
| May 13, 2022 | Barclays | maintain | — → Overweight | $7 | 53% |
| Jan 6, 2022 | Wells Fargo | downgrade | Overweight → Equal-Weight | $16 | 54% |
| Nov 30, 2021 | JMP Securities | initiate | — → Market Outperform | $20 | 53% |
| Oct 8, 2021 | Baird | downgrade | Outperform → Neutral | $10 | 55% |
| Apr 28, 2021 | Guggenheim | downgrade | Buy → Neutral | $0 | 52% |
| Mar 16, 2021 | Baird | upgrade | Neutral → Outperform | $39 | 55% |
| Oct 15, 2020 | Baird | downgrade | Outperform → Neutral | $0 | 55% |
| Aug 19, 2020 | Citigroup | upgrade | Neutral → Buy | $32 | 54% |
| Jul 7, 2020 | Baird | maintain | — → Outperform | $21 | 55% |
| Mar 6, 2020 | Goldman Sachs | downgrade | Neutral → Sell | $11 | 54% |
| Feb 19, 2020 | BTIG | maintain | — → Buy | $39 | 52% |
| Aug 9, 2019 | BTIG | initiate | — → Buy | $0 | 52% |
| Mar 14, 2019 | William Blair | initiate | — → Outperform | $0 | 48% |
| Dec 19, 2018 | Goldman Sachs | initiate | — → Neutral | $25 | 54% |
| Jul 16, 2018 | Barclays | initiate | — → Overweight | $50 | 53% |
| Jun 12, 2018 | Oppenheimer | maintain | Outperform → Outperform | $44 | 52% |
| Mar 16, 2018 | Guggenheim | initiate | — → Neutral | $0 | 52% |
| Sep 6, 2017 | Nomura | maintain | — → Buy | $43 | — |
| Mar 2, 2017 | Nomura | initiate | — → Buy | $0 | — |
| Apr 5, 2016 | Ladenburg Thalmann | initiate | — → Buy | $0 | 45% |
| Jul 20, 2015 | B of A Securities | initiate | — → Buy | $50 | 53% |
| May 22, 2015 | Oppenheimer | initiate | — → Outperform | $65 | 52% |
| Apr 20, 2015 | Jefferies | initiate | — → Buy | $46 | 52% |
| Apr 20, 2015 | Piper Sandler | initiate | — → Overweight | $42 | 54% |
Price Target Trend
Apr 13, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days